News
-
27th January 2022 - Press notes
This is a new valid marker for diagnosing this type of tumour, one of the cancers with the worst prognosis. It is, in fact, the third leading cause of cancer death in developed countries. The study, published in the journal eBioMedicine, was led by researchers from the Hospital del Mar Medical Research Institute and IBB-CSIC-IDIBAPS. Their results point to a protein present in tumour cells as an indicator of pancreatic cancer in early stages of the disease. This marker can be detected through a simple blood test, facilitating its application in clinical practice.
more information
-
15th July 2021 - Press notes
Two professionals from the Laboratory will travel to the Japanese capital to support the anti-doping task that will be carried out during the Olympic Games, which begin on July 23.
more information
-
16 September, 2021 - Press notes
Older adults who are overweight or obese who stick most closely to the Mediterranean diet preserve their cognitive performance and even improve their abilities after three years, according to a study led by researchers at the Hospital del Mar Medical Research Institute, IDIBELL, Hospital de Bellvitge and the CIBEROBN, published in the journal Clinical Nutrition. Memory improvements are proportional to the level of adherence to the Mediterranean diet, weight loss and increased physical activity. At the same time, these changes translate into improvements in people's quality of life. The work is based on the PREDIMED-PLUS trial and shows that women and people with less education gain less benefit on a cognitive level from this type of dietary intervention. This leads the researchers to support the personalisation of these approaches in order to maximise the benefit.
more information
-
9 September, 2021 - Press notes
Researchers from the Hospital del Mar Medical Research Institute (IMIM) have discovered a novel mechanism through which the serotonin receptor interacts with cell membranes in the human brain. This finding opens the door for the design of novel drugs, which could treat central nervous system disorders.
more information
-
6 August, 2021 - Press notes
The team led by Dr. Edurne Arriola and Dr. Beatriz Bellosillo will receive a grant from Thermo Fisher Scientific for their research on the application of liquid biopsy in patients with metastatic small cell lung cancer. The aim is to determine new treatment and prognostic biomarkers in patients with this type of tumour. They will also look for possible new therapeutic targets. This innovative project is one of four selected from around the world to be promoted within the Oncomine Clinical Research Grant programme, and it will look at data from 300 patients with this pathology.
more information
-
10 August, 2021 - Press notes
The Director of the Healthcare and Medical Area, head of the General and Digestive Surgery Service and co-coordinator of the Clinical and Translational Research Group on Colorectal Neoplasms at the Hospital del Mar Medical Research Institute, is one of the top specialists among Catalan digestive surgeons.
more information
-
29th July, 2021 - Press notes
Researchers at the Hospital del Mar Medical Research Institute have shown for the first time how small areas of proteins on the surface of neurones control cell response by binding to neurotransmitters. Evolution has led to the existence of proteins with variations in these areas, capable of causing different cellular responses. This makes it possible to precisely regulate the neurone's response to the same neurotransmitter. It paves the way for the development of specific molecules that block areas linked to certain mental illnesses, such as schizophrenia, or to addictive behaviour. It is the first time it has been possible to see how neurotransmitters and proteins interact at the atomic level to trigger neuronal responses. The study has been published in the journal Chemical Science.
more information
-
21th July, 2021 - Press notes
A 1% increase in this substance in the blood is associated with a change in mortality risk similar to that of quitting smoking. Conversely, being a smoker cancels out the positive effect of eating oily fish, the main source of omega-3 acids. The study, published in The American Journal of Clinical Nutrition, analysed data from more than 2,000 people participating in a population-based follow-up programme in the United States. Their progress has been studied over an eleven-year period. The researchers will try to validate the data using a European population.
more information
-
15th July 2021 - Press notes
Two professionals from the Laboratory will travel to the Japanese capital to support the anti-doping work that will take place during the Olympic Games, which begin on July 23.
more information
-
13th July 2021 - Press notes
Combining chemotherapy with a BRAF oncogene inhibitor proves effective at treating this disease. The study, published in the journal Oncogene, was led by researchers from the Hospital del Mar Medical Research Institute, Hospital del Mar and CIBERONC. This alternative paves the way towards a new approach for patients affected by this type of tumour, which has no cure in the most advanced stages or cases of relapse.
more information